Potential Alzheimer’s Vaccine Undergoing Pre-Clinical Trial Tests

Potential Alzheimer’s Vaccine Undergoing Pre-Clinical Trial Tests
Scientists have developed a novel form of vaccine targeting the two main proteins triggering Alzheimer’s disease, amyloid-beta and tau protein. Researchers and physicians have seen an increase in Alzheimer’s disease, with more than 7.5 million new cases diagnosed worldwide per year. There is an urgent but still unmet need for a vaccine and effective treatment for dementia, one

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.


  1. Jill Craner says:

    I have a strong history of AD on both sides of my family. I am a retired nurse at age 62. I would like to participate in the clinical trials for the vaccine. How can I do this in my area Springfield, Il?

    • Janet says:

      I found a trial (search for number NCT02579252) but it looks like it’s not available to healthy participants, only people with diagnosed Alzheimer’s disease.

    • Janet says:

      You may be eligible for nutrition intervention study at Rush in Chicago when you turn 65 for healthy people with family history of dementia. Or you can just try to follow that diet yourself. Search for NCT02817074

  2. William Peterson says:

    My wife was diagnosed with Alzheimer’s disease last year. Her father also died of Alzheimer’s disease. She would like to participate in clinical trials of the vaccine. We live in Phoenix, AZ.

Leave a Comment

Your email address will not be published. Required fields are marked *